Rocio Pereira, MD

Recognitions

• Excellence in Research Award, NIH, NIDDK (2009)
  Network for Minority Research Investigators

Publications

• Pereira RI, Diaz-Thomas A, Hinton A Jr, Myers AK. A call to action following the US Supreme Court affirmative action ruling. Lancet. 2024 Jan 27;403(10424):332-335. PubMed PMID: 38104576
• Ramzy LM, Monson SP, Chao HW, Hileman B, Podewils LJ, Pereira RI. Power Dynamics Perpetuate DEI Inaction: A Qualitative Study of Community Health Clinic Teams. Ann Fam Med. 2024 May-Jun;22(3):203-207. PubMed PMID: 38806273
• Ni K, Tampe CA, Sol K, Cervantes L, Pereira RI. Continuous Glucose Monitor: Reclaiming Type 2 Diabetes Self-efficacy and Mitigating Disparities. J Endocr Soc. 2024 Jul 1;8(8):bvae125. PubMed PMID: 38974988
• Ikizler TA, Kramer HJ, Beddhu S, Chang AR, Friedman AN, Harhay MN, Jimenez EY, Kistler B, Kukla A, Larson K, Lavenburg LU, Navaneethan SD, Ortiz J, Pereira RI, Sarwer DB, Schauer PR, Zeitler EM. ASN Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases. J Am Soc Nephrol. 2024 Nov 1;35(11):1574-1588. PubMed PMID: 39292519
• Pereira RI. Continuous Glucose Monitoring Access-Addressing Racial and Ethnic Disparities in Diabetes. JAMA Netw Open. 2024 Nov 4;7(11):e2445324. PubMed PMID: 39576653
• Ni K, Tampe CA, Sol K, Richardson DB, Pereira RI. Effect of CGM Access Expansion on Uptake Among Patients on Medicaid With Diabetes. Diabetes Care. 2023 Feb 1;46(2):391-398. PubMed PMID: 36480729
• Finn E, Schlichting L, Grau L, Douglas IS, Pereira RI. Real-world Accuracy of CGM in Inpatient Critical and Noncritical Care Settings at a Safety-Net Hospital. Diabetes Care. 2023 Oct 1;46(10):1825-1830. PubMed PMID: 37561954
• Thompson DA, Haemer MA, Krebs NF, Pereira RI, Moss A, Furniss AL, Bonczynski J, Nicklas JM. A WIC-Based Behavior Change Intervention for Postpartum Women With Overweight and Obesity: A Pilot Feasibility Randomized Trial. Health Promot Pract. 2023 May 25;:15248399231173704. [Epub ahead of print] PubMed PMID: 37226873
• Ni K, Tampe CA, Sol K, Richardson DB, Pereira RI. Effect of CGM Access Expansion on Uptake Among Patients on Medicaid With Diabetes. Diabetes Care. 2023 Feb 1;46(2):391-398. PubMed PMID: 36480729
• Cervantes L, Hazel CA, Mancini D, Pereira RI, Podewils LJ, Stella SA, Durfee J, Barshney A, Steiner JF. Perspectives of Latinx Individuals Who Were Unvaccinated And Hospitalized for COVID-19: A Qualitative Study. JAMA Netw Open. 2022 Jun 1;5(6):e2218362. PubMed PMID: 35713898
• Roncoroni J, Pereira RI, Patel MS, García P. A Mixed Method Examination of Sleep Patterns and Barriers to Sleep in Hispanic Women. J Immigr Minor Health. 2022 Jun;24(3):673-681. PubMed PMID: 34529211
• Pereira, RI. Disparities in Diabetes Care and Evidence-Based Programs to Address Them. 2022 Endocrine Case Management: Meet the Professor e-book. Endocrine society.
• Dhaliwal R, Pereira RI, Diaz-Thomas AM, Powe CE, Yanes Cardozo LL, Joseph JJ. Eradicating Racism: An Endocrine Society Policy Perspective. J Clin Endocrinol Metab. 2022 Apr 19;107(5):1205-1215. PubMed PMID: 35026013
• Pereira RI, Cervantes L. Reducing the Burden of CKD among Latinx: A Community-Based Approach. Clin J Am Soc Nephrol. 2021 Jan 13. [Epub ahead of print] PubMed PMID: 33441466
• Siega-Riz AM, Pace ND, Butera NM, Van Horn L, Daviglus ML, Harnack L, Mossavar-Rahmani Y, Rock CL, Pereira RI, Sotres-Alvarez D. How Well Do U.S. Hispanics Adhere to the Dietary Guidelines for Americans? Results from the Hispanic Community Health Study/Study of Latinos. Health Equity. 2019;3(1):319-327. PubMed PMID: 31338484
• Cox-York K, Pereira RI. Biomarkers of Insulin Resistance. Chapter in Zeitleer P, Nadeau K (eds) : Insulin Resistance: Childhood Precursors and Adult Disease. Humana, Totowa, NJ, 2019.
• Alman AC, Smith SR, Eckel RH, Hokanson JE, Burkhardt BR, Sudini PR, Wu Y, Schauer IE, Pereira RI, Snell-Bergeon JK. The ratio of pericardial to subcutaneous adipose tissues is associated with insulin resistance. Obesity (Silver Spring). 2017 Jul;25(7):1284-1291. PubMed PMID: 28558132
• Park YM, Pereira RI, Erickson CB, Swibas TA, Cox-York KA, Van Pelt RE. Estradiol-mediated improvements in adipose tissue insulin sensitivity are related to the balance of adipose tissue estrogen receptor a and ß in postmenopausal women. PLoS One. 2017;12(5):e0176446. PubMed PMID: 28472101
• Krantz MJ, Havranek EP, Pereira RI, Beaty B, Mehler PS, Long CS. Effects of omega-3 fatty acids on arterial stiffness in patients with hypertension: a randomized pilot study. J Negat Results Biomed. 2015 Dec 2;14:21. PubMed PMID: 26631058
• Pereira RI, Low Wang CC, Wolfe P, Havranek EP, Long CS, Bessesen DH. Associations of Adiponectin with Adiposity, Insulin Sensitivity, and Diet in Young, Healthy, Mexican Americans and Non-Latino White Adults. Int J Environ Res Public Health. 2015 Dec 22;13(1). PubMed PMID: 26703682
• Pereira RI, Casey BA, Swibas TA, Erickson CB, Wolfe P, Van Pelt RE. Timing of Estradiol Treatment After Menopause May Determine Benefit or Harm to Insulin Action. J Clin Endocrinol Metab. 2015 Dec;100(12):4456-62. PubMed PMID: 26425886
• Pereira RI, Snell-Bergeon JS, Erickson C, Schauer I, Bergman B, Rewers M, Maahs D. Adiponectin dysregulation and insulin resistance in Type 1 Diabetes. JCEM 97:E0000-E0000, 2012.
• Pereira RI, Snell-Bergeon JS, Erickson C, Schauer I, Bergman B, Rewers M, Maahs D. Adiponectin dysregulation and insulin resistance in Type 1 Diabetes. JCEM 97(4):E642-7, 2012.
• Miller MR, Pereira RI, Langefeld CD, Lorenzo C, Rotter JI, Chen YD, Bergmenan RN, Wagenknecht LE, Norris JM, Fingerlin TE. Levels of fasting free fatty acids (FFAs) are associated with insulin resistance, but do no mediate the relationship between adiposity and insulin resistance in Hispanic Americans: The IRAS Family Study. JCEM, July 3, 2012.
• Rasouli N, Seggelke S, Gibbs J, Hawkins RM, Casciano ML, Cohlmia E, Taylor-Cousar J, Wang C, Pereira RI, Hsia E, Draznin B. Cystic fibrosis-related diabetes: inpatient management. Journal of Diabetes Science and Technology, vol. 6 (5), 1038-1044, 2012.
• Circulating adiponectin levels are lower in Latino versus non-Latino white patients at risk for cardiovascular disease, independent of adiposity measures. BMP Endocrine Diseases. Accepted with revisions.
• Pereira RI, Wang CCL, Hosokawa P, Dickinson M, Chonchol M, Krantz M, Steiner JF, Bessesen DH, Havranek EP, Long C. Circulating adiponectin levels are lower in Latino versus non-Latino white patients at risk for cardiovascular disease, independent of Pereira; March 5, 2012 Page 7 of 7 adiposity measures. BMC Endocrine Disorders 11:13, 2011.
• RI Pereira, J Leitner, and B Draznin. Pioglitazone stimulates adiponectin secretion from 3T3-L1 Adipocytes via activation of the phosphatidylinositol 3'-kinase. J Invest Med 56(1):192, 2008.
• Pereira RI, Leitner JW, Erickson C, Draznin B. Pioglitazone Acutely Stimulates Adiponectin Secretion from Mouse and Human Adipocytes via Activation of the Phosphatidylinositol 3-kinase. Life Sciences 83:638-743, 2008.
• Pereira RI, Maahs D. Mediators of Insulin Resistance. Chapter in Zeitler P, Nadeau K (eds): Insulin Resistance and Metabolic Syndrome: Childhood Precursors and Adult Diseases. Humana, Totowa, NJ, 2008.
• Pereira RI, Zapalowski C. A Case of Normocalcemic Elevations of Parathyroid Hormone after Parathyroidectomy : An Autoimmune Phenomenon ? EndoTrends 12(4):20-22, 2006.
• Pereira RI, Barbour LA. Update on Osteoporosis. Postgradute Obstetrics & Gynecology 26(16), 2006.
• Mediators of Insulin Resistance. Chapter in Insulin Resistance and Metabolic Syndrome: Childhood Precursors and Adult Disease, Eds. Nadeau and Zeitler, Humana Press, in press.
• RI Pereira, JW Leitner, C Erickson, and B Draznin. Pioglitazone acutely stimulates adiponectin secretion from mouse and human adipocytes via activation of the phosphatidylinositol 3'-kinase. Submitted for publication, March 2008.

Professional Memberships

• Endocrine Society, Member
• American Diabetes Association, Member

Practice Locations

• Denver Health Medical Center
• University of Colorado Hospital

Specialty Information

• Endocrinology, Diabetes and Metabolism, Board Certification (2004)

• Endocrine System (Hormones)